Key Performance Indicators of Clinical Trials in JapanImplications for Reducing the Drug Lag

被引：0
|
作者：
Michinori Terada
Mamoru Narukawa
Masahiro Takeuchi
机构：
[1] Kitasato University,Department of Pharmaceutical Medicines, Graduate School of Pharmaceutical Sciences
[2] Clinical Research,Tokyo Laboratories
[3] Pfizer Global R&D,undefined
来源：
Pharmaceutical Medicine | 2009年 / 23卷 / 5-6期
关键词：
Azithromycin; Recruitment Rate; Project Assistant; Source Data Verification; Investigational Review Board;
D O I：
10.1007/BF03256786
中图分类号：
学科分类号：
摘要：
Background: In Japan, the launch of new drugs is often delayed compared with other major regions, including the US and European countries. This so-called ‘drug lag’ is a significant problem because patients are being denied access to new and potentially life-saving therapies.
引用
收藏
页码：305 / 308
页数：3
相关论文
共 50 条
  • [1] Relationship between drug lag and factors associated with clinical trials in Japan
    Ohwaki, K.
    Nakabayashi, T.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (06) : 649 - 652
  • [2] Key indicators of phase transition for clinical trials through machine learning
    Feijoo, Felipe
    Palopoli, Michele
    Bernstein, Jen
    Siddiqui, Sauleh
    Albright, Tenley E.
    DRUG DISCOVERY TODAY, 2020, 25 (02) : 414 - 421
  • [3] KEY PERFORMANCE INDICATORS
    Chambers, David W.
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2013, 144 (03): : 242 - +
  • [4] Improving membrane photobioreactor performance by reducing light path: operating conditions and key performance indicators
    Gonzalez-Camejo, J.
    Aparicio, S.
    Jimenez-Benitez, A.
    Paches, M.
    Ruano, M., V
    Borras, L.
    Barat, R.
    Seco, A.
    WATER RESEARCH, 2020, 172
  • [5] The impact of a clinical support platform on stroke key performance indicators
    Alanati, Khaled
    O'Brien, William
    Evans, James
    INTERNATIONAL JOURNAL OF STROKE, 2019, 14 : 16 - 16
  • [6] THE IMPACT OF A CLINICAL SUPPORT TOOL ON STROKE KEY PERFORMANCE INDICATORS
    Alanati, Khaled
    Evans, James
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (E7):
  • [7] Key performance indicators of OR efficiency. Myths and evidence of key performance indicators in OR management
    Schuster, M.
    Wicha, L. L.
    Fiege, M.
    ANAESTHESIST, 2007, 56 (03): : 259 - 271
  • [8] Implementation of renal key performance indicators: Promoting improved clinical practice
    Toussaint, Nigel D.
    McMahon, Lawrence P.
    Dowling, Gregory
    Soding, Jenny
    Safe, Maria
    Knight, Richard
    Fair, Kathleen
    Linehan, Leanne
    Walker, Rowan G.
    Power, David A.
    NEPHROLOGY, 2015, 20 (03) : 184 - 193
  • [9] What are the appropriate clinical pharmacy key performance indicators for hospital pharmacists?.
    Fernandes, Olavo
    Gorman, Sean
    Slavik, Richard
    Semchuk, William
    Doucette, Douglas
    Bannerman, Heather
    Lo, Jennifer
    Shukla, Simone
    Chan, Winnie
    Benninger, Natalie
    MacKinnon, Neil
    Bell, Chaim
    Slobodan, Jeremy
    Lyder, Catherine
    Zed, Peter
    Toombs, Kent
    PHARMACOTHERAPY, 2013, 33 (10): : E208 - E208
  • [10] Reasoning with Key Performance Indicators
    Barone, Daniele
    Jiang, Lei
    Amyot, Daniel
    Mylopoulos, John
    PRACTICE OF ENTERPRISE MODELING, 2011, 92 : 82 - +
12345